339 related articles for article (PubMed ID: 27247947)
1. Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases.
Cheng P; Zhang F; Yu L; Lin X; He L; Li X; Lu X; Yan X; Tan Y; Zhang C
J Diabetes Res; 2016; 2016():1540267. PubMed ID: 27247947
[TBL] [Abstract][Full Text] [Related]
2. A review of fibroblast growth factor 21 in diabetic cardiomyopathy.
Zhang X; Yang L; Xu X; Tang F; Yi P; Qiu B; Hao Y
Heart Fail Rev; 2019 Nov; 24(6):1005-1017. PubMed ID: 31175491
[TBL] [Abstract][Full Text] [Related]
3. FGF21 ameliorates diabetic cardiomyopathy by activating the AMPK-paraoxonase 1 signaling axis in mice.
Wu F; Wang B; Zhang S; Shi L; Wang Y; Xiong R; Pan X; Gong F; Li X; Lin Z
Clin Sci (Lond); 2017 Aug; 131(15):1877-1893. PubMed ID: 28559425
[TBL] [Abstract][Full Text] [Related]
4. The role of FGF21 in the pathogenesis of cardiovascular disease.
Zhang Y; Liu D; Long XX; Fang QC; Jia WP; Li HT
Chin Med J (Engl); 2021 Dec; 134(24):2931-2943. PubMed ID: 34939977
[TBL] [Abstract][Full Text] [Related]
5. FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation.
Yan X; Chen J; Zhang C; Zhou S; Zhang Z; Chen J; Feng W; Li X; Tan Y
J Cell Mol Med; 2015 Jul; 19(7):1557-68. PubMed ID: 25823710
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 21 protects the heart from oxidative stress.
Planavila A; Redondo-Angulo I; Ribas F; Garrabou G; Casademont J; Giralt M; Villarroya F
Cardiovasc Res; 2015 Apr; 106(1):19-31. PubMed ID: 25538153
[TBL] [Abstract][Full Text] [Related]
7. Effects of fibroblast growth factor 21 on the heart.
Tanajak P; Chattipakorn SC; Chattipakorn N
J Endocrinol; 2015 Nov; 227(2):R13-30. PubMed ID: 26341481
[TBL] [Abstract][Full Text] [Related]
8. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway.
Zhang C; Huang Z; Gu J; Yan X; Lu X; Zhou S; Wang S; Shao M; Zhang F; Cheng P; Feng W; Tan Y; Li X
Diabetologia; 2015 Aug; 58(8):1937-48. PubMed ID: 26040473
[TBL] [Abstract][Full Text] [Related]
10. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
Iglesias P; Selgas R; Romero S; Díez JJ
Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
[TBL] [Abstract][Full Text] [Related]
11. FGF21 as a mediator of adaptive responses to stress and metabolic benefits of anti-diabetic drugs.
Kim KH; Lee MS
J Endocrinol; 2015 Jul; 226(1):R1-16. PubMed ID: 26116622
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor (FGF21) protects mouse liver against D-galactose-induced oxidative stress and apoptosis via activating Nrf2 and PI3K/Akt pathways.
Yu Y; Bai F; Liu Y; Yang Y; Yuan Q; Zou D; Qu S; Tian G; Song L; Zhang T; Li S; Liu Y; Wang W; Ren G; Li D
Mol Cell Biochem; 2015 May; 403(1-2):287-99. PubMed ID: 25701356
[TBL] [Abstract][Full Text] [Related]
13. FGF21 and Cardiac Physiopathology.
Planavila A; Redondo-Angulo I; Villarroya F
Front Endocrinol (Lausanne); 2015; 6():133. PubMed ID: 26379627
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor 21 as a possible endogenous factor inhibits apoptosis in cardiac endothelial cells.
Lü Y; Liu JH; Zhang LK; DU J; Zeng XJ; Hao G; Huang J; Zhao DH; Wang GZ; Zhang YC
Chin Med J (Engl); 2010 Dec; 123(23):3417-21. PubMed ID: 22166524
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 21 - a key player in cardiovascular disorders?
Lenart-Lipińska M; Duma D; Hałabiś M; Dziedzic M; Solski J
Horm Mol Biol Clin Investig; 2016 Jun; 30(2):. PubMed ID: 27305706
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.
Woo YC; Xu A; Wang Y; Lam KS
Clin Endocrinol (Oxf); 2013 Apr; 78(4):489-96. PubMed ID: 23134073
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Approaches to Alzheimer's Type of Dementia: A Focus on FGF21 Mediated Neuroprotection.
Taliyan R; Chandran SK; Kakoty V
Curr Pharm Des; 2019; 25(23):2555-2568. PubMed ID: 31333086
[TBL] [Abstract][Full Text] [Related]
18. The protective effect of fibroblast growth factor-21 in alcoholic cardiomyopathy: a role in protecting cardiac mitochondrial function.
Ferrer-Curriu G; Guitart-Mampel M; Rupérez C; Zamora M; Crispi F; Villarroya F; Fernández-Solà J; Garrabou G; Planavila A
J Pathol; 2021 Feb; 253(2):198-208. PubMed ID: 33125701
[TBL] [Abstract][Full Text] [Related]
19. The role of fibroblast growth factor 21 in atherosclerosis.
Kokkinos J; Tang S; Rye KA; Ong KL
Atherosclerosis; 2017 Feb; 257():259-265. PubMed ID: 28012645
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice.
Kim HW; Lee JE; Cha JJ; Hyun YY; Kim JE; Lee MH; Song HK; Nam DH; Han JY; Han SY; Han KH; Kang YS; Cha DR
Endocrinology; 2013 Sep; 154(9):3366-76. PubMed ID: 23825123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
